A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Henk M Lokhorst*, Bronno van der Holt, Sonja Zweegman, Edo Vellenga, Sandra Croockewit, Marinus H. van Oers, Peter von dem Borne, Pierre Wijermans, M Ron Schaafsma, Okke de Weerdt, Shulamiet Wittebol, Michel Delforge, Henriette Berenschot, Gerard M. Bos, Kon-Siong G. Jie, Harm Sinnige, Marinus van Marwijk-Kooy, Peter Joosten, Monique C. Minnema, Rianne van AmmerlaanPieter Sonneveld

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1113-1120
JournalBlood
Volume115
Issue number6
DOIs
Publication statusPublished - 11 Feb 2010

Cite this